Skip to content
AI IntelligenceMar 29, 2026AI Intelligence
Article

Eli Lilly signs a multi-billion dollar deal with AI drug developer Insilico Medicine.

The $2.75 billion partnership shows the pharmaceutical industry's high expectations for AI-driven drug discovery. AI aims to accelerate the lengthy and expensive development process.

Data Cube AI EditorialSource: The Decoder
01

Source Brief

Eli Lilly signs a multi-billion dollar deal with AI drug developer Insilico Medicine. The $2.75 billion partnership shows the pharmaceutical industry's high expectations for AI-driven drug discovery. AI aims to accelerate the lengthy and expensive development process.